INGRESAR
CREAR CUENTA
Artículos
Tratamiento médico, endoscópico y quirúrgico | 04 AGO 19

Hemorragia por várices gástricas

Las várices son una de las principales manifestaciones clínicas de la cirrosis y la hipertensión portal.
1
Autor/a: Lee EW, Shahrouki P, Alanis L, Ding P, Kee ST JAMA Surg 2019: 154(6): 540-548
INDICE:  1. Texto principal | 2. Texto principal
Texto principal
  1. Gines P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7(1):122-128.
  2. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217-231.
  3. Groszmann RJ, Garcia-Tsao G, Bosch J, et al; Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353 (21):2254-2261.
  4. Casado M, Bosch J, Garcia-Pagan JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998; 114(6):1296-1303.
  5. D’Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131(5): 1611-1624.
  6. Thuluvath PJ, Krok KL. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time? Am J Gastroenterol. 2005;100(9):1981-1983.
  7. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33(5):846-852.
  8. North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. N Engl J Med. 1988;319(15):983- 989.
  9. Northup PG,Wanamaker RC, Lee VD, Adams RB, Berg CL. Model for End-Stage Liver Disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg. 2005;242(2):244-251.
  10. Kim HJ, Lee HW. Important predictor of mortality in patients with end-stage liver disease. Clin Mol Hepatol. 2013;19(2):105-115.
  11. Abraldes JG, Villanueva C, Banares R, et al; Spanish Cooperative Group for Portal Hypertension and Variceal Bleeding. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol. 2008;48(2):229-236.
  12. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol. 2008;48(suppl 1): S68-S92.
  13. de Franchis R; Baveno VI Faculty. Expandingconsensus in portal hypertension: report of the Baveno VI ConsensusWorkshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743-752.
  14. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1): 310-335.
  15. Wilbur K, Sidhu K. Beta blocker prophylaxis for patients with variceal hemorrhage. J Clin Gastroenterol. 2005;39(5):435-440.
  16. Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2008;92(3):551-574, viii. viii.
  17. Merkel C, Marin R, Angeli P, et al; Gruppo Triveneto per l’Ipertensione Portale. A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology. 2004;127(2):476-484.
  18. TrudeauW, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc. 1986;32(4):264-268.
  19. Ali SM,Wu S, Xu H, Liu H, Hao J, Qin C. A prospective study of endoscopic injection sclerotherapy and endoscopic variceal ligation in the treatment of esophageal varices. J Laparoendosc Adv Surg Tech A. 2017;27(4):333-341.
  20. Tantau M, Crisan D, Popa D, Vesa S, Tantau A. Band ligation vs. N-Butyl-2-cyanoacrylate injection in acute gastric variceal bleeding: a prospective follow-up study. Ann Hepatol. 2013;13(1):75-83.
  21. Kang EJ, Jeong SW, Jang JY, et al. Long-term result of endoscopic Histoacryl (N-butyl-2- cyanoacrylate) injection for treatment of gastric varices. World J Gastroenterol. 2011;17(11):1494-1500.
  22. Rajoriya N, Forrest EH, Gray J, et al. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM. 2011;104(1):41-47.
  23. Martins FP, Macedo EP, Paulo GA, Nakao FS, Ardengh JC, Ferrari AP. Endoscopic follow-up of cyanoacrylate obliteration of gastric varices. Arq Gastroenterol. 2009;46(1):81-84.
  24. Paik CN, Kim SW, Lee IS, et al. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome. J Clin Gastroenterol. 2008;42(8):916-922.
  25. Seewald S, Ang TL, Imazu H, et al. A standardized injection technique and regimen ensures success and safety of N-butyl-2- cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointest Endosc. 2008;68(3):447-454.
  26. Cheng LF,Wang ZQ, Li CZ, et al. Treatment of gastric varices by endoscopic sclerotherapy using butyl cyanoacrylate: 10 years’ experience of 635 cases. Chin Med J (Engl). 2007;120(23):2081-2085.
  27. Lo GH, Liang HL, ChenWC, et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy. 2007;39(8):679-685.
  28. Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology. 2006; 43(4):690-697.
  29. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am J Gastroenterol. 2002;97(4): 1010-1015.
  30. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33(5):1060-1064.
  31. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52(2):160-167.
  32. Shiha G, El-Sayed SS. Gastric variceal ligation: a new technique. Gastrointest Endosc. 1999;49 (4 Pt 1):437-441.
  33. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc. 1997;46(1):8-14.
  34. Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy. 1995;27(5): 349-354.
  35. Ramond MJ, Valla D, Mosnier JF, et al. Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology. 1989;10(4): 488-493.
  36. de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43 (1):167-176.
  37. Van Stiegmann G. Update of endoscopic band ligation therapy for treatment of esophageal varices. Endoscopy. 2003;35(8):S5-S8.
  38. Hong CH, Kim HJ, Park JH, et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 2009;24(3): 372-378.
  39. Lim YS. Practical approach to endoscopic management for bleeding gastric varices. Korean J Radiol. 2012;13(suppl 1):S40-S44.
  40. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126(4):1175-1189.
  41. Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management. J Clin Gastroenterol. 2011;45(2):133-148.
  42. Sarin SK, Lahoti D. Management of gastric varices. Baillieres Clin Gastroenterol. 1992;6(3):527- 548.
  43. Herrera JL. Management of acute variceal bleeding. Clin Liver Dis. 2014;18(2):347-357.
  44. Kerlan RK Jr, LaBerge JM, Gordon RL, Ring EJ. Transjugular intrahepatic portosystemic shunts: current status. AJR AmJ Roentgenol. 1995;164(5): 1059-1066.
  45. Sabri SS, Abi-Jaoudeh N, SweeW, et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol. 2014;25(3):355-361.
  46. Sanyal AJ, Freedman AM, Luketic VA, et al. The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts. Gastroenterology. 1997;112(3):889-898.
  47. Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003;4(2):109-116.
  48. Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR AmJ Roentgenol. 2004;183(2):369-376.
  49. Ferral H, Gamboa P, Postoak DW, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004;231(1):231-236.
  50. Al-Osaimi AM, Caldwell SH. Medical and endoscopic management of gastric varices. Semin Intervent Radiol. 2011;28(3):273-282.
  51. Funaro AH, Ring EJ, Freiman DB, Oleaga JA, Gordon RL. Transhepatic obliteration of esophageal varices using the stainless steel coil.AJR AmJ Roentgenol. 1979;133(6):1123-1125.
  52. Scott J, Dick R, Long RG, Sherlock S. Percutaneous transhepatic obliteration of gastro-oesophageal varices. Lancet. 1976;2(7976): 53-55.
  53. Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR AmJ Roentgenol. 1984;143(3):627-628.
  54. Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okud
« Página anterior
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
Hemorragia no controlada por úlcera péptica
Hemorragia gastrointestinal superior aguda
» Centro de Atención IntraMed
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024